Searching across hundreds of databases
The antitumor effector T helper 1 (Th1) and Th17 cells represent two T cell paradigms: short-lived cytolytic Th1 cells and "stem cell-like" memory Th17 cells. We report that Th9 cells represent a third paradigm-they are less-exhausted, fully cytolytic, and hyperproliferative. Only tumor-specific Th9 cells completely eradicated advanced tumors, maintained a mature effector cell signature with cytolytic activity as strong as Th1 cells, and persisted as long as Th17 cells in vivo. Th9 cells displayed a unique Pu.1-Traf6-NF-κB activation-driven hyperproliferative feature, suggesting a persistence mechanism rather than an antiapoptotic strategy. Th9 antitumor efficacy depended on interleukin-9 and upregulated expression of Eomes and Traf6. Thus, tumor-specific Th9 cells are a more effective CD4+ T cell subset for adoptive cancer therapy.
Pubmed ID: 29894691 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Software package for interpreting gene expression data. Used for interpretation of a large-scale experiment by identifying pathways and processes.
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets c-Rel
View all literature mentionsThis unknown targets NFkB p50/p105
View all literature mentionsThis monoclonal targets Phospho-I B (Ser32)
View all literature mentionsThis unknown targets LAT, phospho (Tyr191)
View all literature mentionsThis monoclonal targets Phospho-Src Family (Tyr416) (D49G4) Rabbit mAb
View all literature mentionsThis monoclonal targets Phospho-PLCγ1 (Tyr783)
View all literature mentionsThis monoclonal targets beta-Actin
View all literature mentionsThis unknown targets PLC gamma 1
View all literature mentionsThis monoclonal targets CD3 (CD3-12) Rat mAb
View all literature mentionsThis unknown targets Lck, phospho (Tyr505)
View all literature mentionsThis monoclonal targets Phospho-Zap-70 (Tyr319)/Syk (Tyr352)
View all literature mentionsThis monoclonal targets Zap70
View all literature mentionsThis polyclonal targets MAP3K7
View all literature mentionsThis monoclonal targets CYLD (D1A10) Rabbit mAb
View all literature mentionsThis unknown targets Histone Deacetylase 1 (HDAC1)
View all literature mentionsThis monoclonal targets NFAT2 (D15F1) Rabbit mAb
View all literature mentionsThis monoclonal targets NFAT1 (D9C2) Rabbit mAb
View all literature mentionsThis unknown targets RelB
View all literature mentionsThis monoclonal targets NF-κB p65
View all literature mentionsThis unknown targets Src
View all literature mentionsThis polyclonal targets IKBKG, OPTN
View all literature mentionsThis polyclonal targets CHUK, IKBKB
View all literature mentionsThis polyclonal targets NFKBIB
View all literature mentionsThis monoclonal targets Human CD247
View all literature mentionsThis monoclonal targets CD178.1
View all literature mentionsThis monoclonal targets IFNγ
View all literature mentionsThis monoclonal targets IL-2
View all literature mentionsThis monoclonal targets IL-4
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD16/32
View all literature mentionsThis monoclonal targets EOMES
View all literature mentionsThis recombinant monoclonal targets Granzyme B
View all literature mentionsThis monoclonal targets IL-2
View all literature mentionsThis monoclonal targets IL-17A
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets IL-9
View all literature mentionsThis monoclonal targets CD244.2
View all literature mentionsThis monoclonal targets CD223
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets KLRG1
View all literature mentionsThis monoclonal targets Ki-67
View all literature mentionsThis monoclonal targets CD127
View all literature mentionsThis monoclonal targets CD197
View all literature mentionsThis monoclonal targets CD122
View all literature mentionsThis monoclonal targets CD62L
View all literature mentionsThis monoclonal targets CD44
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsMus musculus with name B6.129S7-Ifngtm1Ts/J from IMSR.
View all literature mentionsMus musculus with name B6.129S1(Cg)-Eomestm1.1Bflu/J from IMSR.
View all literature mentions
Mus musculus with name B6.SJL-Ptprca Pepc
Mus musculus with name B6.Cg-Rag1tm1Mom Tyrp1
Mus musculus with name B6.Cg-Tg(TcraTcrb)425Cbn/J from IMSR.
View all literature mentionsMus musculus with name STOCK Tg(Cd4-cre)1Cwi/BfluJ from IMSR.
View all literature mentionsMus musculus with name B6.129S2(C)-Stat6tm1Gru/J from IMSR.
View all literature mentionsMus musculus with name B6.129S2-Cd8atm1Mak/J from IMSR.
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
